CI vs TXMD · P/E 2.4, rev $274.90B vs rev $1.8M
Cigna Corp (CI) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the CI and TXMD stock pages for the full models.
Not investment advice.